![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Xenetic Biosciences Inc is a biopharmaceutical company focused on progressing XCART, a personalized CAR T platform technology engineered to target patient-specific tumor neoantigens. The company is initially advancing cell-based therapeutics targeting B-cell receptor on the surface of an individual ... Xenetic Biosciences Inc is a biopharmaceutical company focused on progressing XCART, a personalized CAR T platform technology engineered to target patient-specific tumor neoantigens. The company is initially advancing cell-based therapeutics targeting B-cell receptor on the surface of an individual patient's malignant tumor cells for the treatment of B-cell lymphomas. XCART has the potential to fuel a pipeline of therapeutic assets targeting oncology indications. It also has oncology therapeutic investigational drug candidate XBIO-101 for the treatment of progestin resistant endometrial cancer. Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 4.16 | 4.4404 | 4.04 | 8049 | 4.16617011 | CS |
4 | -0.34 | -7.55555555556 | 4.5 | 4.5 | 3.73 | 7600 | 4.11382983 | CS |
12 | 0.19 | 4.78589420655 | 3.97 | 4.5 | 3.51 | 5248 | 4.02234077 | CS |
26 | 0.66 | 18.8571428571 | 3.5 | 4.74 | 3.07 | 5422 | 4.05467753 | CS |
52 | -0.07 | -1.6548463357 | 4.23 | 5.97 | 2.8696 | 6219 | 4.09213192 | CS |
156 | -14.14 | -77.2677595628 | 18.3 | 56.8 | 2.40101 | 912484 | 29.6655982 | CS |
260 | -52.94 | -92.7145359019 | 57.1 | 60 | 2.40101 | 880659 | 27.23475704 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions